Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma-Reference-Cited by-同舟云学术

Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma

Published:2017 Issue:15 Volume:56 Page:1967-1971
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Muraishi Junichi¹,Shibata Michihiko¹,Honma Yuichi¹,Hiura Masaaki¹,Abe Shintaro¹,Harada Masaru¹

Affiliation:

1. Third Department of Internal Medicine, Japan School of Medicine, University of Occupational and Environmental Health, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/15/56_56.8233/_pdf

Reference25 articles.

1. 1. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 50: 661-662, 2009.

2. 2. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2: 479-486, 2002.

3. 3. Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol 6: 384-393, 2014.

4. 4. Coppola N, Tonziello G, Pisaturo M, et al. Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. J Med Virol 83: 1909-1916, 2011.

5. 5. Tsubouchi H, Kumada H, Kiyosawa K, et al. Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis. Kanzo 50: 38-42, 2009.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occult hepatitis B in Iranian blood donors, an overview of the challenges: A narrative review;Health Science Reports;2023-07-31

2. Risk management to prevent hepatitis B reactivation by a hepatologist;Kanzo;2022-10-01

3. Very late-onset hepatitis B reactivation following chemoimmunotherapy;Leukemia & Lymphoma;2021-12-02

4. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies;Frontiers in Oncology;2021-07-01

5. Rapid loss of HBs antigen in patients with HBV reactivation and high level of transaminases during immunosuppressive therapy - case series;Revista Romana de Medicina de Laborator;2021-01-01